Brivanib inhibits VEGFR -2 with an IC50 of 25 nmol/l and a Ki of 26 nmol/l, VEGFR-1 with an IC50 of 380 nmol/l and VEGFR-3 with an IC50 of 10 nmol/l. It also shows selectivity for FGFR-1 with an IC50 of 148 nmol/l, FGFR-2 with an IC50 of 25nmol/l and FGFR-3 with an IC50 of 68 nmol/l.
Product Details
| Formula: | C22H24FN5O4 |
| |
| MW: | 441.5 |
| |
| CAS: | 649735-63-7 |
| |
| Purity: | ≥97% (HPLC) |
| |
| Identity: | Determined by EM-MS, NMR |
| |
| Appearance: | Yellow powder. |
| |
| Solubility: | Soluble in DMSO (74mg/ml) or ethanol (3mg/ml). |
| |
| Shipping: | Ambient |
| |
| Short Term Storage: | +4°C |
| |
| Long Term Storage: | -20°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
